Curing blindness and improving the vision is one of the key issues in front of researchers and the health experts. One of the research study claims that blindness can be cured with the help of gene therapy. FD members will soon hold a panel to decide whether to approve the use of this technique or not.
FDA members will conduct this meeting on October 12, in which the effectiveness of gene therapy in curing the hereditary blindness condition will be considered. This new gene therapy is known as Luxturna which is designed by the researchers from Philadelphia. However, this technique does not work on all the individuals suffering from hereditary blindness. The Luxturna technique does not promise to completely restore the vision of the blind people but it is a safe technique.
During the experiment, it was seen that the individuals who were suffering from this condition have gained some vision. This Luxturna will be the first gene therapy technique which will be used in the United States to cure the inherited conditions like blindness. In future, more such techniques can be used to cure the inherited conditions.
In this therapy, the corrected gene is directly inserted into the individual so that his vision can be restored. Luxturna technique can efficiently correct the faulty genes since it can efficiently produce the protein which can help in restoring the vision. With this technique, individuals will be able to see some blurred faces and lights.
Parents who have faulty gene goes unnoticed due to which their child is also born blind. But now if FDA approves the Luxturna technique than it can effectively treat this condition. Although this therapy can efficiently cure blindness, it is now yet known how long the effectiveness of this treatment will remain.
It is expected that by January, FDA may approve this gene therapy which can help millions of blind people. However, one of the drawbacks of this technique is that it is very expensive due to which ordinary people cannot afford it. In Europe, this therapy was performed on 2 individuals and the cost was $1 million. It will be interesting to see, how this technique can help millions of blind people present globally.